Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Alex on +44 1494 818021 or alex@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Alex Reynolds
Account Manager
alex@zenopa.com
+44 1494 818021

Testimonials
I've been associated with Zenopa for few months now and since registering I've always found the entire team to be professional and helpful in choosing my new sales position with a private sector compa...
Tushar, 2012

Takeda operating income falls 40.9 per cent

3 February 2009 00:00 in Pharmaceutical Company Financials


Takeda's operating income has decreased by 166 billion yen (1.3 billion pounds), according to the organisation's nine-month results.

Now standing at 239.9 billion yen, the figure was accompanied by a fall in the organisation's net profits, which saw a reduction of almost half (49.1 per cent) to 168.6 billion yen.

However, the company's net sales increased 11.8 per cent to 1,202.8 billion yen.

Takeda noted the figures were the impact of restructuring its US operations through division and consolidation, along with its acquisition of Millennium.

The company continued it "pays keen attention" to changes in business environment and closely monitors the risk factors that affect its activity, "in order to make steady efforts towards achieving sustained growth of sales and profits".

In November last year, Takeda's board of directors announced a plan to increase interim and annual dividends per share for the fiscal year ending March 31st 2009.

Founded in 1781, the company is based in Osaka, Japan.

Other news stories from 03/02/2009

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd